arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2602.18496cs.CV
收藏

针对非小细胞肺癌的自适应放疗患者专用数字双胞胎

A Patient-Specific Digital Twin for Adaptive Radiotherapy of Non-Small Cell Lung Cancer

Yale University(耶鲁大学);University of Guam(关岛大学);University of North Carolina at Chapel Hill(北卡罗来纳大学教堂山分校)

Anvi Sud, Jialu Huang, Gregory R. Hart, Keshav Saxena, John Kim, Lauren Tressel, Jun Deng

AI总结:

COMPASS通过整合PET、CT、剂量组学等数据,构建患者专用数字双胞胎,用于自适应放疗中的早期毒性预警。

摘要:

放疗持续变得更加精确和数据密集,当前的治疗方案生成高频成像和剂量学流,非常适合由AI驱动的时间建模来表征正常组织随时间的变化。在生物引导放疗(BGRT)中,每个分次治疗非小细胞肺癌(NSCLC)患者都会记录新的代谢、解剖和剂量信息。然而,临床决策主要由静态的、基于人群的NTCP模型驱动,这些模型忽略了在连续数据中编码的动态、独特的生物轨迹。我们开发了COMPASS(全面个性化评估系统),用于安全放疗,它作为利用每分次PET、CT、剂量组学、放射组学和累积生物等效剂量(BED)动力学的时序数字双胞胎架构,以建模正常组织生物学作为动态时间序列过程。采用GRU自编码器学习器官特定的潜在轨迹,通过逻辑回归分类来预测最终CTCAE 1级或以上的毒性。八名接受BGRT的NSCLC患者贡献了99个器官分次观察,涵盖了24个器官轨迹(脊髓、心脏和食管)。尽管样本量小,密集的时间表型分析使我们能够全面分析个体剂量反应动态。我们的发现揭示了一个可行的AI驱动的早期预警窗口,随着风险评分在临床毒性之前几个分次增加。密集的BED驱动的表示揭示了在毒性之前出现的相关空间剂量纹理特征,这些特征在传统基于体积的剂量学中被平均掉。COMPASS为AI驱动的自适应放疗建立了概念验证,其中治疗由一个持续更新的数字双胞胎引导,跟踪每个患者不断演变的生物反应。

英文摘要:

Radiotherapy continues to become more precise and data dense, with current treatment regimens generating high frequency imaging and dosimetry streams ideally suited for AI driven temporal modeling to characterize how normal tissues evolve with time. Each fraction in biologically guided radiotherapy(BGRT) treated non small cell lung cancer (NSCLC) patients records new metabolic, anatomical, and dose information. However, clinical decision making is largely informed by static, population based NTCP models which overlook the dynamic, unique biological trajectories encoded in sequential data. We developed COMPASS (Comprehensive Personalized Assessment System) for safe radiotherapy, functioning as a temporal digital twin architecture utilizing per fraction PET, CT, dosiomics, radiomics, and cumulative biologically equivalent dose (BED) kinetics to model normal tissue biology as a dynamic time series process. A GRU autoencoder was employed to learn organ specific latent trajectories, which were classified via logistic regression to predict eventual CTCAE grade 1 or higher toxicity. Eight NSCLC patients undergoing BGRT contributed to the 99 organ fraction observations covering 24 organ trajectories (spinal cord, heart, and esophagus). Despite the small cohort, intensive temporal phenotyping allowed for comprehensive analysis of individual dose response dynamics. Our findings revealed a viable AI driven early warning window, as increasing risk ratings occurred from several fractions before clinical toxicity. The dense BED driven representation revealed biologically relevant spatial dose texture characteristics that occur before toxicity and are averaged out with traditional volume based dosimetry. COMPASS establishes a proof of concept for AI enabled adaptive radiotherapy, where treatment is guided by a continually updated digital twin that tracks each patients evolving biological response.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑